Amgen signals beyond the news: 45+ signals from 4 sources
The latest Amgen signal on this page is from Oct 30, 2026 (Reddit): "Amgen received a warning from the FDA over a promotional video for a cancer drug, according to a Reuters report shared by a commenter." The busiest sources: Glassdoor (15+), LinkedIn (15+) and Patents (10).
Get Amgen's live signals in Claude or ChatGPT, or by API
What changed at Amgen this week? Use Autobound signals for amgen.com.- Signals
- 45+
- Sources
- 4
- Last 90 days
- 16
- Latest
- Oct 30, 2026
Source: Autobound Signal API · 79 signals tracked for Amgen · updated
Other signals · latest 10
Latest Amgen signals by source
45+ signals for Amgen across 4 sources.
Reddit · Legal action
Amgen received a warning from the FDA over a promotional video for a cancer drug, according to a Reuters report shared by a commenter.
Post: "Amgen people, are you doing good?"
- Subreddit
- r/clinicalresearch
- Upvotes
- 44
- Comments
- 38
- Sentiment
- Negative
Patents · Patent grant
Amgen was granted a patent for continuous biologics manufacturing.
In October 2026 Amgen patented an integrated production process for making and packaging biologic medicines in pharmaceutical manufacturing facilities.
- Patent title
- Continuous manufacturing process for biologics manufacturing by integration of drug substance and drug product processes
- Grant date
- Oct 27, 2026
- Inventors
- Subramanian Guhan, Malhar R. Ambhaikar, Vincent Chai, Sai Chakradhar Padala
Patents · Patent grant
Amgen was granted a patent for a wearable drug delivery device.
In October 2026 Amgen patented a wearable device designed to administer medication while being worn on the body, supporting at-home or ambulatory treatment.
- Patent title
- Wearable drug delivery device
- Grant date
- Oct 27, 2026
- Inventors
- Margaux Frances Boyaval, Sigrid Moeslinger, Lisa Nugent, Brian Stonecipher
Patents · Patent pace
Amgen Inc.'s patent output is steady: 116 grants in the past year, 9 in the past 30 days.
Over the past year Amgen Inc. received 116 US patent grants, concentrated in image processing / graphics and video / streaming; the recent pace (38 in 90 days) is steady versus its trailing baseline.
- Grants, 12 months
- 116
- Grants, 90 days
- 38
- Grants, 30 days
- 9
- USPTO assignee
- AMGEN INC.
Reddit · Customer feedback
Amgen is considered a great place to work with good work-life balance, but its systems are described as clunky.
Post: "Sponsor & FSP Rankings"
- Subreddit
- r/clinicalresearch
- Upvotes
- 40
- Comments
- 16
- Sentiment
- Mixed
Reddit · Product change
Amgen closed its department for managing clinical trial biospecimens and replaced dedicated staff with an outsourced team in India, resulting in significant service delays.
Post: "Sponsor/FSP Rankings"
- Subreddit
- r/clinicalresearch
- Upvotes
- 24
- Comments
- 46
- Sentiment
- Negative
LinkedIn
Amgen hosts annual Advocacy Summit with over 130 global organizations.
You're looking at more than 130 advocacy organizations from around the world representing communities across cardiovascular disease, cancer, inflammation, obesity and rare disease. They came together at Amgen's annual Advocacy Summit to share insights, learn from one another and explore both the progress being made...
- Likes
- 344
- Comments
- 18
- Tags
- Partnership, Healthcare Technology, Corporate Strategy, Sustainability
- Initiatives
- annual Advocacy Summit with patient advocacy organizations
LinkedIn
Amgen announces Q2 2026 earnings with a link to a safe harbor statement.
Amgen reports Q2 2026 earnings: https://amgen.ly/4yZw6AF Safe Harbor: https://amgen.ly/4fRSL9g
- Likes
- 357
- Comments
- 2
- Tags
- Financial Reporting, Earnings
Glassdoor · Compensation dissatisfaction
Employees report low salary and below market standard salary revisions
Reviews indicate low salaries and salary revisions that are below market standards, causing dissatisfaction.
- Overall rating
- 4.1 of 5
- CEO approval
- 65%
- Reviews read
- 8
- Review window
- Feb 18, 2026 to Mar 9, 2026
Glassdoor · Reorg chaos
Frequent reorganizations mentioned every two years causing instability
One review notes that Amgen experiences many reorganizations, occurring every two years, which can lead to instability.
- Overall rating
- 4.1 of 5
- CEO approval
- 65%
- Reviews read
- 8
- Review window
- Feb 18, 2026 to Mar 9, 2026
Showing 10 of 45+ signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Amgen with the Signal API
One POST /v1/companies/enrich call with amgen.com returns Amgen signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "amgen.com",
"signal_types": ["reddit-company","podcast-company","glassdoor-company",
"product-reviews","linkedin-post-company","twitter-company-posts",
"youtube-company","website-intelligence","patents-company",
"federal-contract-award","conference-speaker","hackernews",
"producthunt-launch","seo-traffic"],
"limit": 20
}'Bulk data
Need these signals for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file).
Same industry
Other signals at related companies
Questions about Amgen other signals
What signals does Autobound track for Amgen besides news and filings?
What are people saying about Amgen online?
What do employees say about working at Amgen?
Has Amgen been granted patents recently?
Page updated , the date of the newest row on this page.
Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.
Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.
Data as of .